M B Khazaeli - JoVE Visualize

Showing results (91-100 of 104) with videos related to

Pageof 11

Sort By:

Critical Care Medicine|December 1, 1990

Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndromeC J Fisher, J Zimmerman, M B Khazaeli, et al.

Human Antibodies and Hybridomas|January 1, 1992

Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanomaM N Saleh, M B Khazaeli, R H Wheeler, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1994

Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49R F Meredith, A J Bueschen, M B Khazaeli, et al.

Human Pathology|November 11, 2003

Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinomaDavid C Chhieng, Cristina Rodriguez-Burford, Lynya I Talley, et al.

Cancer Biotherapy & Radiopharmaceuticals|August 24, 2005

Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion proteinAndres Forero-Torres, Sui Shen, Hazel Breitz, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996

Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49R F Meredith, E E Partridge, R D Alvarez, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999

Targeting strategies for cancer radiotherapyD J Buchsbaum, B E Rogers, M B Khazaeli, et al.

Gynecologic Oncology|April 1, 1997

Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II studyR D Alvarez, E E Partridge, M B Khazaeli, et al.

Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001

Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I studyR F Meredith, R D Alvarez, E E Partridge, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancerF Robert, M P Ezekiel, S A Spencer, et al.

Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:

Pageof 11

Critical Care Medicine|December 1, 1990

Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndromeC J Fisher, J Zimmerman, M B Khazaeli, et al.

Human Antibodies and Hybridomas|January 1, 1992

Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanomaM N Saleh, M B Khazaeli, R H Wheeler, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1994

Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49R F Meredith, A J Bueschen, M B Khazaeli, et al.

Human Pathology|November 11, 2003

Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinomaDavid C Chhieng, Cristina Rodriguez-Burford, Lynya I Talley, et al.

Cancer Biotherapy & Radiopharmaceuticals|August 24, 2005

Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion proteinAndres Forero-Torres, Sui Shen, Hazel Breitz, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996

Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49R F Meredith, E E Partridge, R D Alvarez, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999

Targeting strategies for cancer radiotherapyD J Buchsbaum, B E Rogers, M B Khazaeli, et al.

Gynecologic Oncology|April 1, 1997

Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II studyR D Alvarez, E E Partridge, M B Khazaeli, et al.

Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001

Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I studyR F Meredith, R D Alvarez, E E Partridge, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancerF Robert, M P Ezekiel, S A Spencer, et al.

Pageof 11